(MedPage Today) — The FDA granted accelerated approval to telisotuzumab vedotin (Emrelis) for the treatment of adults with previously treated, locally advanced, or metastatic non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein…
Source link : https://www.medpagetoday.com/hematologyoncology/lungcancer/115586
Author :
Publish date : 2025-05-14 20:48:00
Copyright for syndicated content belongs to the linked Source.
